JPH0576473B2 - - Google Patents

Info

Publication number
JPH0576473B2
JPH0576473B2 JP59021529A JP2152984A JPH0576473B2 JP H0576473 B2 JPH0576473 B2 JP H0576473B2 JP 59021529 A JP59021529 A JP 59021529A JP 2152984 A JP2152984 A JP 2152984A JP H0576473 B2 JPH0576473 B2 JP H0576473B2
Authority
JP
Japan
Prior art keywords
methyl
product
acid
reaction
reference example
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59021529A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59152378A (ja
Inventor
Daburyu Raian Chaaruzu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23843341&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH0576473(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS59152378A publication Critical patent/JPS59152378A/ja
Publication of JPH0576473B2 publication Critical patent/JPH0576473B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Credit Cards Or The Like (AREA)
JP59021529A 1983-02-07 1984-02-07 ニザチジン合成法 Granted JPS59152378A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46429683A 1983-02-07 1983-02-07
US464296 1983-02-07

Publications (2)

Publication Number Publication Date
JPS59152378A JPS59152378A (ja) 1984-08-31
JPH0576473B2 true JPH0576473B2 (US06380249-20020430-C00034.png) 1993-10-22

Family

ID=23843341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59021529A Granted JPS59152378A (ja) 1983-02-07 1984-02-07 ニザチジン合成法

Country Status (27)

Country Link
EP (1) EP0116452B1 (US06380249-20020430-C00034.png)
JP (1) JPS59152378A (US06380249-20020430-C00034.png)
KR (1) KR860000767B1 (US06380249-20020430-C00034.png)
AT (1) ATE84530T1 (US06380249-20020430-C00034.png)
AU (1) AU559639B2 (US06380249-20020430-C00034.png)
BG (1) BG45216A3 (US06380249-20020430-C00034.png)
CA (1) CA1221369A (US06380249-20020430-C00034.png)
CS (1) CS240994B2 (US06380249-20020430-C00034.png)
DD (1) DD216459A5 (US06380249-20020430-C00034.png)
DE (1) DE3486032T2 (US06380249-20020430-C00034.png)
DK (2) DK164501C (US06380249-20020430-C00034.png)
EG (1) EG17702A (US06380249-20020430-C00034.png)
ES (1) ES529492A0 (US06380249-20020430-C00034.png)
FI (1) FI840474A (US06380249-20020430-C00034.png)
GB (1) GB2134521B (US06380249-20020430-C00034.png)
GR (1) GR81755B (US06380249-20020430-C00034.png)
HU (2) HU194198B (US06380249-20020430-C00034.png)
IE (1) IE56763B1 (US06380249-20020430-C00034.png)
IL (1) IL70880A (US06380249-20020430-C00034.png)
NZ (1) NZ207046A (US06380249-20020430-C00034.png)
PH (1) PH19941A (US06380249-20020430-C00034.png)
PL (1) PL138793B1 (US06380249-20020430-C00034.png)
PT (1) PT78063A (US06380249-20020430-C00034.png)
RO (1) RO87706A (US06380249-20020430-C00034.png)
SU (1) SU1303028A3 (US06380249-20020430-C00034.png)
UA (1) UA6020A1 (US06380249-20020430-C00034.png)
ZA (1) ZA84869B (US06380249-20020430-C00034.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA869438B (en) * 1985-12-18 1988-07-27 Lilly Co Eli Synthesis of nizatidine
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5583768A (en) * 1978-12-18 1980-06-24 Bristol Myers Co Organic compound
JPS5791980A (en) * 1980-10-02 1982-06-08 Lilly Co Eli 2,4-disubstituted thiazole derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5583768A (en) * 1978-12-18 1980-06-24 Bristol Myers Co Organic compound
JPS5791980A (en) * 1980-10-02 1982-06-08 Lilly Co Eli 2,4-disubstituted thiazole derivatives

Also Published As

Publication number Publication date
DE3486032D1 (de) 1993-02-25
CS240994B2 (en) 1986-03-13
ATE84530T1 (de) 1993-01-15
CS81284A2 (en) 1985-06-13
CA1221369A (en) 1987-05-05
RO87706A (ro) 1985-10-31
DK51984A (da) 1984-08-08
DE3486032T2 (de) 1993-05-19
DK21292D0 (da) 1992-02-19
EP0116452A2 (en) 1984-08-22
AU2421584A (en) 1984-08-16
GR81755B (US06380249-20020430-C00034.png) 1984-12-12
KR860000767B1 (ko) 1986-06-23
DK164501B (da) 1992-07-06
GB2134521B (en) 1986-10-01
KR840007591A (ko) 1984-12-08
PH19941A (en) 1986-08-14
DD216459A5 (de) 1984-12-12
JPS59152378A (ja) 1984-08-31
HU194198B (en) 1988-01-28
FI840474A (fi) 1984-08-08
GB2134521A (en) 1984-08-15
IL70880A (en) 1987-01-30
RO87706B (ro) 1985-10-01
PT78063A (en) 1984-03-01
DK164501C (da) 1992-11-23
EG17702A (en) 1991-03-30
NZ207046A (en) 1986-06-11
EP0116452A3 (en) 1987-04-29
UA6020A1 (uk) 1994-12-29
ES8601941A1 (es) 1985-11-01
HU190527B (en) 1986-09-29
DK21292A (da) 1992-02-19
ZA84869B (en) 1985-09-25
GB8403109D0 (en) 1984-03-07
DK164906C (da) 1993-01-25
IE840274L (en) 1984-08-07
EP0116452B1 (en) 1993-01-13
ES529492A0 (es) 1985-11-01
SU1303028A3 (ru) 1987-04-07
IL70880A0 (en) 1984-05-31
PL138793B1 (en) 1986-11-29
AU559639B2 (en) 1987-03-19
PL246097A1 (en) 1985-06-04
DK164906B (da) 1992-09-07
DK51984D0 (da) 1984-02-06
BG45216A3 (US06380249-20020430-C00034.png) 1989-04-14
FI840474A0 (fi) 1984-02-06
IE56763B1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
JPS61207369A (ja) 3つの置換基を有する安息香酸中間体
JPS626718B2 (US06380249-20020430-C00034.png)
KR20020033617A (ko) 2,2-디메틸-1,3-디옥산 중간체의 염 및 그것의 제조방법
JPH0576473B2 (US06380249-20020430-C00034.png)
JP2001064282A (ja) イミダゾリン化合物、その中間体、およびそれらの製造方法、並びにアゼピン化合物およびその塩の製造方法
JP2009518380A (ja) 2−クロロエトキシ−酢酸−n,n−ジメチルアミドの製法
JPH0742269B2 (ja) 4−アルコキシ−3−ピロリン−2−オン−1−イル−酢酸アルキルエステルおよびその製造方法
JP2001521498A (ja) O−(3−アミノ−2−ヒドロキシ−プロピル)−ヒドロキシミック酸ハロゲン化物の製造方法
WO2004087640A1 (en) Process for the manufacture of n-alkoxalyl-alaninates
HU208320B (en) Process for producing 0-carboxypyridyl and 0-carboxyquinolyl imidazolinones
CN112272665A (zh) 制备立他司特的方法
US4587344A (en) Isothiourea synthesis process
KR890001241B1 (ko) 4-아세틸 이소퀴놀리논 화합물의 제조방법
KR860001568B1 (ko) 선택적 설폰화 방법에 의한 페닐렌디아민 유도체의 제조 방법
KR100187734B1 (ko) 지방족 아미드 및 그의 염의 제조 방법
JP3037399B2 (ja) イミダゾール誘導体の製法
JP4172931B2 (ja) 1−アルキル−5−ハイドロキシピラゾールの製造法
JPH0641066A (ja) ピロール誘導体の製造方法
KR100288188B1 (ko) 페닐프로피온산 유도체 또는 그의 염의 제조방법
JP2002069030A (ja) ナトリウム2−{4−[(2−オキソシクロペンチル)メチル]フェニル}プロピオネート2水和物の製造法
JPS6259106B2 (US06380249-20020430-C00034.png)
JPH0414114B2 (US06380249-20020430-C00034.png)
JPS58164573A (ja) 1−(4−クロロベンゾイル)−5−メトキシ−2−メチル−3−インド−ルアセトキシ酢酸類の製法
JPS6155496B2 (US06380249-20020430-C00034.png)
NO153077B (no) Foldemonopolantenne med en bardunert og nedentil jordet mast